Insights On Pharmaceutical Production
-
Innovative Preservation Solutions For Cell Therapy
4/18/2024
The low efficiency and poor biocompatibility of conventional preservatives hinder successful cell preservation. Explore solutions to enhance the stability and post-thaw viability of cell therapy products.
-
The Role Of The Technical Transfer Executive Sponsor
10/30/2023
Explore the importance of understanding a CDMO’s flexibility and culture, models and scale of equipment, technical capabilities, regulatory support, quality system, and executive sponsorship model.
-
Process Control And Performance Of A Virus Filtration System
1/12/2023
Discover a single-use automated filtration system designed to deliver robust process control and integrity assurance during the critical purification step. Explore its design features, processing control, and more.
-
An Introduction To Isolated Robotic Aseptic Filling Systems
11/16/2023
Watch as Josh Russell, VP of Sales and Marketing, AST, demonstrates the GENiSYS® C aseptic filling system, ideal for use in small-scale filling applications.
-
Plasmid DNA Downstream Purification Process
4/11/2023
Large scale production of plasmid DNA requires an in-depth understanding and optimization of the entire downstream process. Explore a complete solution, from harvest to bulk filtration.
-
Multicolor Microscopy: The Importance Of Multiplexing
6/8/2023
Avoid the misleading effects of fluorescent crosstalk during imaging, find out how to select the right combination of fluorophores, and explore other approaches to avoid crosstalk during multiplexing experiments.
-
Strategies For Scaling Up mRNA Manufacturing To Address Vaccine Demand
4/17/2024
Learn how flexible approaches can help address the considerations and hurdles in mRNA manufacturing.
-
How To Perform Fast And Stable Multicolor Live-Cell Imaging
5/25/2023
Researchers studying living cells and animals can benefit from this live-cell imaging technology allowing researchers to generate reliable results for both short and long-term experiments.
-
Risk Mitigation For Late-Stage Clinical Assets
10/9/2023
Leveraging the competence and capabilities of the CDMO to bring forth innovative, flexible solutions to safeguard supply chains for their clients and, ultimately, for patients is crucial to strategic partnering.
-
Method Migration Of The USP Ibuprofen Assay And Organic Impurities Method
3/15/2023
An isocratic USP monograph for ibuprofen and related organic impurities was used to assess a method migration between HPLC systems. Explore results that demonstrate the ability to migrate methods.